EGAPP supplementary evidence review: DNA testing strategies aimed at reducing morbidity and mortality from Lynch syndrome-Reference-Cited by-同舟云学术

EGAPP supplementary evidence review: DNA testing strategies aimed at reducing morbidity and mortality from Lynch syndrome

Published:2009-01 Issue:1 Volume:11 Page:42-65
ISSN:1098-3600
Container-title:Genetics in Medicine
language:en
Short-container-title:Genetics in Medicine

Author:

Palomaki Glenn E.,McClain Monica R.,Melillo Stephanie,Hampel Heather L.,Thibodeau Stephen N.

Publisher

Elsevier BV

Subject

Genetics (clinical)

Reference133 articles.

1. Bonis PA, Trikalinos TA, Chung M, et al. Hereditary nonpolyposis colorectal cancer: accuracy of diagnostic strategies and implications to patients with colorectal cancer and their families. Evidence report/technology assessment No. 07-E008. Rockville, MD: Agency for Healthcare Research and Quality, 2007.

2. Recommendations from the EGAPP Working Group: Genetic testing strategies in newly diagnosed individuals with colorectal cancer aimed at reducing morbidity and mortality from Lynch syndrome in relatives;EGAPP Working Group;Genet Med,2009

Cited by 416 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Information needs persist after genetic counseling and testing for BRCA1/2 and Lynch Syndrome;Breast Cancer Research and Treatment;2024-07-24

2. Evaluation of pathogenic variants detected in high homology regions of the PMS2 gene. How effective is long-range PCR?;Frontiers in Oncology;2024-06-18

3. Role of Annexin 7 (ANXA7) as a tumor suppressor and a regulator of drug resistance in thyroid cancer;2024-05-20

4. National Experiences from 30 Years of Provider-Mediated Cascade Testing in Lynch Syndrome Families—The Danish Model;Cancers;2024-04-20

5. Molecular and Clinicopathologic Characterization of Mismatch Repair-Deficient Endometrial Carcinoma Not Related to MLH1 Promoter Hypermethylation;Modern Pathology;2024-03